Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 8, 2013 - Issue 5
Submit an article Journal homepage
27
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Acquired disorders of the thyroid following treatment for head and neck cancer

Richard O WeinDepartment of Otolaryngology-Head & Neck Surgery, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USACorrespondence[email protected]
Pages 461-467 | Published online: 10 Jan 2014

References

  • Ozawa H, Saitou H, Mizutari K, Takata Y, Ogawa K. Hypothyroidism after radiotherapy for patients with head and neck cancer. Am. J. Otolaryngol. 28(1), 46–49 (2007).
  • Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J. Clin. 55(1), 10–30 (2005).
  • Vidal L, Gillison ML. Human papillomavirus in HNSCC: Recognition of a distinct disease type. Hematol. Oncol. Clin. N. Am. 22, 1125–1142 (2008).
  • Chaturvedi AK, Engels EA, Pfeiffer RM et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29, 4294–4301 (2011).
  • Fakhy C, Westra H, Li S et al. Improved survival of patient s with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. 100, 261–269 (2008).
  • Lassen P, Eriksen JG, Hamilton-Dutoit S et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J. Clin. Oncol. 27(12), 1992–1998 (2009).
  • Posner MR, Lorch JH, Goloubeva O et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international Phase III trial. Ann. Oncol. 22(5), 1071–1077 (2011).
  • Rischin D, Young RJ, Fisher R et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 Phase III trial. J. Clin. Oncol. 28(27), 4142–4148 (2010).
  • Jereczek-Fossa BA, Alterio D, Jassem J et al. Radiotherapy-induced thyroid disorders. Cancer Treat. Rev. 30(4), 369–384 (2004).
  • Mini S, Dori S, Horowitz Z et al. Pretreatment prevalence of hypothyroidism in patients with head and neck carcinoma. Cancer 92, 1512–1515 (2001).
  • Bakhshandeh M, Hashemi B, Mahdavi SRM et al. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck therapy. Int. J. Radiation Oncol. Biol. Phys. 85(2), 514–521 (2013).
  • Miller MC, Agrawal A. Hypothyroidism in postradiation head and neck cancer patients: incidence, complications and management. Curr. Opin. Otolaryngol. Head Neck Surg. 17, 111–115 (2009).
  • Koc M, Capoglu I. Thyroid dysfunction in patients treated with radiotherapy for neck. Am. J. Clin. Oncol. 32(2), 150–153 (2009).
  • Bolling T, Geisenheiser A, Pape H et al. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the “Results for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence” (RiSK). Int. J. Radiat. Oncol. Biol. Phys. 81(5), e787–e791 (2011).
  • Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int. J. Radiat. Oncol. Biol. Phys. 31(5), 1165–1170 (1995).
  • Gui A, Faaruq S, Abbasi NZ et al. Estimation of absorbed dose to thyroid in patients treated with radiotherapy for various cancers. Radiat. Prot. Dosimetry. 156(1), 37–41 (2013).
  • Boomsma MJ, Bijl HP, Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a systemic review. Radiother. Oncol. 99(1), 1–5 (2011).
  • Boomsma MJ, Bijl HP, Christianen ME et al. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. Int. J. Radiat. Oncol. Biol. Phys. 84(3), e351–e356 (2012).
  • Cella L, Liuzzi R, Conson M et al. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat. Oncol. 7, 224 (2012).
  • Lin Z, Wu VWC, Lin J, Feng H, Chen L. A longitudinal study on radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid 21(1), 19–23 (2011).
  • Miller-Thomas MM, Kumar AJ, Sellin RV, Azimpoor S, Ang KK. The shrinking thyroid: How does thyroid size change following radiation therapy for laryngeal cancer? Am. J. Neuroradiol. 30, 613–616 (2009).
  • Chougule A, Kochar B. Thyroid dysfunction following therapeutic external radiation to head and neck cancer. Asian Pacific J. Cancer Prev. 12(11), 443–445 (2011).
  • Nishiyama K, Tanaka E, Tarui Y et al. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int. J. Radiat. Oncol. Biol. Phys. 34(2), 439–434 (1996).
  • Smith GL, Smith BD, Garden AS et al. Hypothyroidism in older patients with head and neck cancer after treatment with radiation: A population-based study. Head Neck 31, 1031–1038 (2009).
  • Kanti AR, Ranjan DA, Santanu P et al. Iatrogenic hypothyroidism: a consequence of external beam radiotherapy to the head & neck malignancies. J. Cancer Res. Ther. 1(3), 142–146 (2005).
  • Munyo-Estefan A, Lopez-Paullier M, Charlone-Granucci R et al. Thyroid function alteration in patients with radiation therapy. Acta Otorrinolaringol. Esp. 60(4), 268–271 (2009).
  • Cetinayak O, Akman F, Kentli S et al. Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer. Tumori 94(1), 19–23 (2008).
  • Diaz R, Jaboin JJ, Morales-Paliza M et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 77(2), 468–476 (2010).
  • Mercado G, Adelstein DJ, Saxton JP et al. Hypothyroidism: A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 92, 2892–2897 (2001).
  • Vogelius IR, Bentzen SM, Maraldo MV, Peterson PM, Specht L. Risk factors for radiation-induced hypothyroidism. Cancer 117, 5250–5260 (2011).
  • Darzy KH, Shalet SM. Hypopituitarism following radiotherapy revisited. Endocr. Dev. 15, 1–24 (2009).
  • Darzy KH, Murray RD, Gleeson HK et al. The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J. Clin. Endocrinol.Metab. 91, 987–994 (2006).
  • Siala W, Mnejja W, Abid M et al. Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma. Ann. Endocrinol. (Paris) 72(1), 19–23 (2011).
  • Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendehall WM. Hypopituitarism after radiotherapy for extracranial head and neck cancers in pediatric patients. Am. J. Clin.Oncol. 31(6), 567–572 (2008).
  • Nishi Y, Hamamoto K, Fijita N, Okada S. Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia. Int. J. Hematol. 94(4), 399–402 (2011).
  • Ron E, Lubin JH, Shore RE et al. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat. Res. 178(2), AV43–AV60 (2012).
  • Veiga LHS, Lubin JH, Anderson H et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat. Res. 178, 365–376 (2012).
  • Mabuchi K, Hatch M, Little MP, Linet MS, Simon SL. Risk of thyroid cancer after adult radiation exposure: Time to re-assess? Radiat. Res. 179, 254–256 (2013).
  • Kovalchik SA, Ronckers CM, Veiga LH et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J. Clin. Oncol. 31(1), 119–127 (2013).
  • Rose J, Wertheim BC, Guerrero MA. Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy. Am. J. Surg. 204(6), 881–887 (2012).
  • Vivanco M, Dalle JH, Alberti C et al. Malignant and benign thyroid nodules after total body irradiation preceding hematopoietic cell transplantation during childhood. Eur. J. Endocrinol. 167(2), 225–233 (2012).
  • Massimino M, Gandola L, Mattavelli F et al. Radiation-induced thyroid changes: a retrospective and a prospective view. Eur. J. Cancer 45(14), 2546–2551 (2009).
  • Sassolas GM, Hafdi-Nejjari Z, Casgranda L et al. Thyroid cancers in children, adolescents, and young adults with and without a history of childhood exposure to therapeutic radiation for cancers. Thyroid 23(7), 805–810 (2013).
  • Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009).
  • de Bree R, Lips P, Leemans CR. The need for patients’ endocrine function vigilance following treatment of head and neck cancer. Curr. Opin. Otolaryngol. Head Neck Surg. 16(2), 154–157 (2008).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.